The company's technology, called Hydropore, overcomes the limitations and costs of existing gene delivery methods like electroporation and viral transduction. It is being developed in collaboration with top pharmaceutical companies and research institutions. Indee Labs has received funding from prominent investors and has opened offices in Sydney and Berkeley.